| 1 |
Zhao Y, Hua X, Ren X, et al. Increasing burden of stroke in China: a systematic review and Meta-analysis of prevalence, incidence, mortality, and case fatality [J]. Int J Stroke, 2023, 18(3): 259-267.
|
| 2 |
GBD 2023 Causes of Death Collaborators. Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023 [J]. Lancet, 2025, 406(10513): 1811-1872.
|
| 3 |
GBD 2023 Disease and Injury and Risk Factor Collaborators. Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023 [J]. Lancet, 2025, 406(10513): 1873-1922.
|
| 4 |
Wang Z, Li J, Long Z, et al. National and provincial trends of mortality and years of life lost due to stroke in children and adolescents in China, 2005-2020: an analysis of national mortality surveillance data [J]. Int J Stroke, 2026, 21(1): 57-67.
|
| 5 |
Wang H, Lin J, Zhang S, et al. Global, regional, and national burden of stroke and its subtypes: unravelling the correlations with the global aging trend [J]. Neuroepidemiology, 2025: 1-20.
|
| 6 |
Wang H, Lin J, Zhao F, et al. Burden of intracerebral hemorrhage in Asia from 1990 to 2030: a population-based study [J]. Neuroepidemiology, 2026, 60(1): 55-68.
|
| 7 |
Huang X, Lu Z, Li T, et al. Comorbidity patterns in patients with first-ever acute ischemic stroke and their associations with functional outcomes [J]. Neuroepidemiology, 2026, 60(1): 91-103.
|
| 8 |
Li S, Gu HQ, Feng B, et al. Safety and efficacy of intravenous recombinant human prourokinase for acute ischaemic stroke within 4.5 h after stroke onset (PROST-2): a phase 3, open-label, non-inferiority, randomised controlled trial [J]. Lancet Neurol, 2024, 24(1): 33-41.
|
| 9 |
Xiong Y, Meng X, Jin A, et al. Prourokinase vs standard care for patients with mild ischemic stroke: the PUMICE randomized clinical trial [J]. JAMA Neurol, 2025, 82(3): 258-266.
|
| 10 |
Zhou Y, He Y, Campbell BCV, et al. Alteplase for acute ischemic stroke at 4.5 to 24 hours: the HOPE randomized clinical trial [J]. JAMA, 2025, 334(9): 788-797.
|
| 11 |
Yan S, Zhou Y, Lansberg MG, et al. Alteplase for posterior circulation ischemic stroke at 4.5 to 24 hours [J]. N Engl J Med, 2025, 392(13): 1288-1296.
|
| 12 |
Miao Z, Luo G, Song L, et al. Intra-arterial tenecteplase for acute stroke after successful endovascular therapy: the ANGEL-TNK randomized clinical trial [J]. JAMA, 2025, 334(7): 582-591.
|
| 13 |
Liu C, Guo C, Li F, et al. Intra-arterial urokinase after endovascular reperfusion for acute ischemic stroke: the POST-UK randomized clinical trial [J]. JAMA, 2025, 333(7): 589-598.
|
| 14 |
Huang J, Yang J, Liu C, et al. Intra-arterial tenecteplase following endovascular reperfusion for large vessel occlusion acute ischemic stroke: the POST-TNK randomized clinical trial [J]. JAMA, 2025, 333(7): 579-588.
|
| 15 |
Hou X, Huang J, Wang L, et al. Intra-arterial tenecteplase after successful reperfusion in large vessel occlusion stroke: a randomized clinical trial [J]. JAMA Neurol, 2025, 82(9): 895-904.
|
| 16 |
Writing Committee for the PEARL Investigators, PEARL investigators. Intra-arterial alteplase after successful endovascular reperfusion in acute stroke: the PEARL randomized clinical trial [J]. JAMA, 2025, 334(19): 1728-1739.
|
| 17 |
Hu W, Tao C, Wang L, et al. Intra-arterial tenecteplase after successful endovascular recanalisation in patients with acute posterior circulation arterial occlusion (ATTENTION-IA): multicentre randomised controlled trial [J]. BMJ, 2025, 388: e080489.
|
| 18 |
Qiu Z, Li F, Sang H, et al. Intravenous tenecteplase before thrombectomy in stroke [J]. N Engl J Med, 2025, 393(2): 139-150.
|
| 19 |
Yang M, Cao YZ, Lv PH, et al. Thrombectomy alone or alongside intravenous thrombolysis in managing acute ischemic stroke caused by basilar artery occlusion: a multicenter observational study [J]. AJNR Am J Neuroradiol, 2025, 46(4): 706-711.
|
| 20 |
Li W, Doheim MF, Qiu Z, et al. Endovascular treatment for acute posterior circulation tandem lesions: insights from the BASILAR and PERSIST registries [J]. J Stroke, 2025, 27(1): 75-84.
|
| 21 |
Luo C, Nguyen TN, Li R, et al. Computed tomography perfusion parameters: a potential tool for treatment selection in basilar artery occlusion [J]. Ann Neurol, 2025, 98(1): 185-196.
|
| 22 |
Huo X, Sun D, Nguyen TN, et al. Endovascular therapy versus medical management for large ischemic infarct: 1-year outcomes of the ANGEL-ASPECT trial [J]. Stroke, 2025, 56(9): 2398-2407.
|
| 23 |
Ma Y, Wang T, Ni W, et al. Long-term follow-up of extracranial-intracranial bypass surgery for symptomatic cerebral artery occlusion [J]. JAMA, 2025, 334(4): 358-360.
|
| 24 |
Li X, Li Y, Wang T, et al. Determining the optimal age for extracranial-intracranial bypass surgery: a post hoc analysis of the CMOSS randomized trial [J]. Stroke, 2025, 56(2): 362-370.
|
| 25 |
Chen JH, Su IC, Lu YH, et al. Predictive modeling of symptomatic intracranial hemorrhage following endovascular thrombectomy: insights from the nationwide TREAT-AIS registry [J]. J Stroke, 2025, 27(1): 85-94.
|
| 26 |
Li L, Song S, Mo D, et al. Factors associated with early reocclusion in recanalized intracranial atherosclerotic occlusion: ANGEL-REBOOT insights [J]. Stroke, 2025, 56(9): 2431-2439.
|
| 27 |
Nie X, Liu J, Yan B, et al. Cerebral edema progression and outcomes in large infarct patients undergoing endovascular thrombectomy [J]. Ann Neurol, 2025, 98(2): 258-269.
|
| 28 |
Luo C, Nguyen TN, Li R, et al. Association between collateral status, blood pressure during thrombectomy, and clinical outcomes in patients with basilar artery occlusion [J]. Neurology, 2025, 104(9): e213504.
|
| 29 |
Leng X, Nie X, Yan H, et al. Collaterals and outcomes after endovascular treatment in acute large vessel occlusion: disparity by stroke etiologies [J]. Int J Stroke, 2025, 20(7): 864-873.
|
| 30 |
Tao C, Liu T, Cui T, et al. Early tirofiban infusion after intravenous thrombolysis for stroke [J]. N Engl J Med, 2025, 393(12): 1191-1201.
|
| 31 |
Zheng L, Liu Y, Nie X, et al. Intravenous tirofiban following endovascular therapy for patients with acute large vessel occlusion stroke [J]. Int J Stroke, 2025: 17474930251386577.
|
| 32 |
Qiao Y, Zhao M, Wang J, et al. Stroke etiology was associated with tirofiban efficacy in acute ischemic stroke without endovascular treatment: a pre-specified subgroup analysis of the TREND trial [J]. Int J Stroke, 2025, 20(8): 977-986.
|
| 33 |
Liu D, Yan H, Gao Y, et al. Effect of history of hypertension on efficacy of clopidogrel-aspirin in ischemic stroke [J]. Int J Stroke, 2025, 20(8): 1021-1030.
|
| 34 |
Chen Y, Jiang L, Gao Y, et al. CYP2C19 genotype and efficacy of clopidogrel initiated between 24 to 72 hours for ischemic stroke [J]. Stroke, 2025, 56(11): 3108-3117.
|
| 35 |
Zhou Q, Gao Y, Chen W, et al. Efficacy and safety of dual antiplatelet treatment up to 72 hours in acute ischemic stroke stratified by glycemic status [J]. Ann Neurol, 2025, 98(1): 174-182.
|
| 36 |
Ma G, Mo R, Yao X, et al. Clinical and safety outcomes of edaravone dexborneol in acute ischemic stroke: a multicenter, prospective, cohort study [J]. Neurology, 2025, 105(4): e213949.
|
| 37 |
Xie X, Zhong C, Liu X, et al. Early versus delayed antihypertensive treatment after acute ischemic stroke by hypertension history [J]. Stroke, 2025, 56(3): 631-639.
|
| 38 |
Yuan X, Gan Q, Zhang Y, et al. Prehospital blood pressure lowering in patients with ischemic stroke: a systematic review and Meta-analysis of randomized controlled trials [J]. Int J Stroke, 2024, 20(3): 289-296.
|
| 39 |
Huang X, Zeng X, Tang L, et al. Subarachnoid hemorrhage and finger-like projection predict recurrence in patients with lobar intracerebral hemorrhage [J]. J Neurol, 2025, 272(2): 166.
|
| 40 |
Lyu T, Xu X, Li G, et al. Prediction of early hematoma enlargement in hypertensive intracerebral hemorrhage using CT and CTA imaging features [J]. Neuroradiology, 2025, 67(7): 1751-1760.
|
| 41 |
Hu X, Wang Z, Liu J, et al. Statin use is associated with reduced risk of incident intracerebral hemorrhage: a prospective population-based cohort study [J]. Int J Stroke, 2025, 20(10): 1280-1289.
|
| 42 |
Li Q, Lv X, Morotti A, et al. Optimal magnitude of blood pressure reduction and hematoma growth and functional outcomes in intracerebral hemorrhage [J]. Neurology, 2025, 104(5): e213412.
|
| 43 |
Hu X, Wang M, Wang Z, et al. Predictors and lesion patterns of dysphagia and swallowing outcomes after acute intracerebral hemorrhage [J]. Ther Adv Neurol Disord, 2025, 18: 17562864241311130.
|
| 44 |
Li S, Wu L, Li N, et al. Early microcirculatory dysfunction on perfusion CT is related to prognosis after aneurysmal subarachnoid hemorrhage [J]. Transl Stroke Res, 2025, 16(5): 1523-1535.
|
| 45 |
Wang H, Yu Q, Zhang W, et al. Enlarged perivascular spaces (EPVS) associated with functional and cognitive outcome after aneurysm subarachnoid hemorrhage (aSAH) [J]. Transl Stroke Res, 2024, 16(4): 1358-1368.
|
| 46 |
An X, Wang B, Ge X, et al. Effectiveness of external ventricular drainage versus lumbar drainage in aneurysmal subarachnoid hemorrhage: a propensity-matched multicenter study [J]. Int J Stroke, 2025, 20(9): 1071-1080.
|
| 47 |
Zeng C, Zhai Y, Ge P, et al. Glymphatic impairment associated with neurocognitive dysfunction in Moyamoya disease [J]. Transl Stroke Res, 2025, 16(3): 690-703.
|
| 48 |
Weng R, Su J, Jiang H, et al. Longitudinal neurocognitive outcomes and predictors after unilateral combined cerebral revascularization in adult moyamoya vasculopathy [J]. J Neurosurg, 2025, 143(6): 1545-1554.
|
| 49 |
Chen C, Gao G, Wang H, et al. Clinical significance of postoperative collateral circulation formation in long-term prognosis and stroke events after EDAS in adults with moyamoya disease [J]. Neurosurg Rev, 2025, 48(1): 570.
|
| 50 |
Xu Y, Wu Y, Jiang M, et al. Efficacy and safety of a dedicated device for cerebral venous thrombectomy: a pilot randomized clinical trial [J]. Stroke, 2025, 56(1): 5-13.
|
| 51 |
Feng Y, Mo S, Li X, et al. Development and validation of a score for clinical deterioration in patients with cerebral venous thrombosis [J]. Neurosurg Rev, 2025, 48(1): 56.
|
| 52 |
Li Y, Tian T, Qin Y, et al. White matter injuries mediate brain age effects on cognitive function in cerebral small vessel disease [J]. Neuroradiology, 2025, 67(3): 613-622.
|
| 53 |
Li B, Zeng B, Zeng P, et al. Thalamic microstructural alterations in cerebral small vessel disease with mild cognitive impairment: insights from diffusion kurtosis imaging [J]. Neuroradiology, 2025, 67(3): 623-641.
|
| 54 |
Wang YC, Zhu HH, He LC, et al. Proteome profiling of serum reveals pathological mechanisms and biomarker candidates for cerebral small vessel disease [J]. Transl Stroke Res, 2025, 16(5): 1606-1620.
|
| 55 |
Liu Q, Nie X, Vergouwen MDI, et al. Gadolinium-enhanced aneurysm wall imaging and risk of intracranial aneurysm growth or rupture [J]. JAMA Neurol, 2025, 82(11): 1135-1143.
|
| 56 |
Peng L, Peng H, Wu N, et al. Potential drug targets for intracranial aneurysms identified through Mendelian randomization analysis [J]. Neurosurg Rev, 2025, 48(1): 683.
|
| 57 |
Wang C, Wang B, Han H, et al. Infratentorial brain arteriovenous malformations: natural history and long-term outcome-a propensity score matched analysis using nationwide multicenter prospective registry data [J]. J Neurointerv Surg, 2025: jnis-2025-023826.
|